PAVE Latin America

Latest news

25 March 2024 New treatment for relapsing malaria, tafenoquine rolled out in Brazil starting with the Yanomami indigenous people

22nd March 2024, the Yanomami Indigenous people, in Roraima, became the first in Brazil to receive tafenoquine and point-of-care glucose-6-phosphate dehydrogenase (G6PD) testing for P. vivax malaria, following the decision of the government to adopt the use of these new health technology innovations.

5 March 2024 Real-world effectiveness of single-dose tafenoquine for P. vivax relapse prevention confirmed in retrospective observational study in Brazil

On 4th March 2024, The Lancet Infectious Diseases published operational real-world effectiveness data confirming the public health and patient benefits of using quantitative G6PD testing and tafenoquine in P. vivax malaria case management in Brazil. 

14 February 2024 The Lancet Global Health publishes groundbreaking results from the Tafenoquine Roll-out STudy (TRuST) in the Brazilian Amazon

The Tafenoquine Roll-out STudy (TRuST) in the Brazilian Amazon, published in Lancet Global Health, demonstrates the operational feasibility of introducing single-dose tafenoquine alongside quantitative G6PD testing for Plasmodium vivax radical cure.

21 Aug 2023 Brazil becomes the first malaria-endemic country to register single-dose tafenoquine for children with relapsing malaria

Brazil has approved single-dose tafenoquine (Kozenis) in children 2 years and above in combination with chloroquine for the radical cure of Plasmodium vivax malaria.

6 June 2023 Brazil becomes the first malaria-endemic country to adopt single-dose tafenoquine and STANDARD G6PD Test for the treatment of relapsing Plasmodium vivax malaria

Medicines for Malaria Venture (MMV) and PATH are excited to announce that Brazil has become the first malaria-endemic country to incorporate the STANDARD trade; G6PD Test and single-dose tafenoquine in the public health system for the treatment of P. vivax malaria.

Pilot Educational Project, Colombia
The Pilot Educational Program (PEP): G6PD Test Training for Health Workers in Colombia
Pilot Educational Program (PEP) Toolbox
Past Meetings and Events
14 November 2023 - 8 AM Seattle | 11 AM Washington | 11 AM Lima/Bogotá | 1 PM Brasilia | 5 PM Geneva Implementation Efforts for New Malaria Tools and Approaches in Latin America

The 2023 PAVE Regional Meeting convened virtually on November 14th, gathering around 120 participants.

11 September 2023 Innovations in the health system: Brazil adopts new tools in pursuit of P. vivax elimination MedTrop Congress – Salvador Conference Center (Av. Octávio Mangabeira, 5.490 - Boca do Rio, Salvador, Brazil)

A celebratory event hosted by Brazil's Minister of Public Health and PAVE to mark the first-ever adoption of G6PD testing and tafenoquine usage for P. vivax malaria in the Brazilian SUS

25 April 2023 World Malaria Day event in Brazil - April 25th, 2023 Belém, Brazil

The Brazilian Ministry of Health (MoH) hosted a meeting on World Malaria Day, April 25th, to reaffirm the government's commitment to eliminating malaria.

25 April 2023 World Malaria Day event in Peru - 25th April 2023 Lima, Peru

The Ministry of Health Peru (MINSA) hosted a World Malaria Day event, inviting the Partnership for Vivax Elimination (PAVE) team to present the actions executed and ongoing in Latin America, and new tools to combat Plasmodium vivax malaria. The event was broadcast in Spanish and was live streamed on Youtube.

De 8 AM Seattle | 11 AM Washington/Bogota/Lima | 1 PM Brasilia| 5 PM Geneva 2022 PAVE Latin America Regional Meeting | Reunião Regional da PAVE América Latina 2022 This meeting will take place virtually

On November 8, 2022, PAVE will host its 3rd Regional Meeting with stakeholders involved in the fight against P. vivax malaria in the Americas.

The Partnership for Vivax Elimination (PAVE) Second Annual Regional Meeting for Latin America

The Partnership for Vivax Elimination (PAVE) organized the second annual Regional Meeting for Latin America, bringing together National Malaria Control Programs from Brazil, Peru and Colombia, along with regional and global organizations involved in the fight against P. vivax malaria in the region. 

14 de setiembre a las 8 am PDT / 11 am AMT Webinar: The validation and operational use of point-of-care G6PD testing in the Brazilian Amazon: A presentation of data from clinical study and real-life settings to inform test performance and considerations for use Online

GORCoP Webinar: The validation and operational use of point-of-care G6PD testing in the Brazilian Amazon.